Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5971-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies

Therapeutic Advances in Hematology
Hematology
2016English

Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.

Postgraduate Medical Journal
Medicine
1994English

Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine

Cancer Management and Research
Oncology
2015English

Ochroconis Gallopava Endophthalmitis in Fludarabine Treated Chronic Lymphocytic Leukaemia

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Chronic Lymphocytic Leukaemia: The Role of T Cells in a B Cell Disease

British Journal of Haematology
Hematology
2019English

Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia

Cancer
Cancer ResearchOncology
2011English

The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma

British Journal of Haematology
Hematology
2008English

Efficancy of Rituximab With Chlorambucil Regimen in Elderly Patients With Chronic Lymphocytic Leukaemia

Hematology & blood transfusion: interdepartamental collection
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy